These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 37042132)

  • 21. Histopathological Correlation of Chromosome 12 Polysomy by Fluorescence in Situ Hybridization in Adipocytic Neoplasms.
    Wilcock DM; McMurtry V; Coleman JF; Kim JT; Khalili P; Deftereos G; Albertson D; Gulbahce EH; Liu T; Sirohi D
    Int J Surg Pathol; 2022 Oct; 30(7):734-742. PubMed ID: 35261272
    [No Abstract]   [Full Text] [Related]  

  • 22. Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.
    Kimura H; Dobashi Y; Nojima T; Nakamura H; Yamamoto N; Tsuchiya H; Ikeda H; Sawada-Kitamura S; Oyama T; Ooi A
    Int J Clin Exp Pathol; 2013; 6(7):1306-16. PubMed ID: 23826411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.
    Aleixo PB; Hartmann AA; Menezes IC; Meurer RT; Oliveira AM
    J Clin Pathol; 2009 Dec; 62(12):1127-35. PubMed ID: 19946100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical lipomatous tumor/well differentiated liposarcoma and related mimics with updates. When is molecular testing most cost-effective, necessary, and indicated?
    Kilpatrick SE
    Hum Pathol; 2024 May; 147():82-91. PubMed ID: 38135062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification.
    Murshed KA; Abo Samra H; Ammar A
    Head Neck Pathol; 2022 Mar; 16(1):288-293. PubMed ID: 34089125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDM2 and CDK4 Immunohistochemistry: Should It Be Used in Problematic Differentiated Lipomatous Tumors?: A New Perspective.
    Clay MR; Martinez AP; Weiss SW; Edgar MA
    Am J Surg Pathol; 2016 Dec; 40(12):1647-1652. PubMed ID: 27508976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carboxypeptidase M: a biomarker for the discrimination of well-differentiated liposarcoma from lipoma.
    Erickson-Johnson MR; Seys AR; Roth CW; King AA; Hulshizer RL; Wang X; Asmann YW; Lloyd RV; Jacob EK; Oliveira AM
    Mod Pathol; 2009 Dec; 22(12):1541-7. PubMed ID: 19820690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paratesticular liposarcoma: the clinicopathological features of nineteen cases].
    Yang SM; Wu RC; Qi SS; You JF
    Zhonghua Bing Li Xue Za Zhi; 2022 Jan; 51(1):17-22. PubMed ID: 34979748
    [No Abstract]   [Full Text] [Related]  

  • 29. MDM4 amplification in atypical lipomatous tumors/well-differentiated liposarcoma: Private event or alternative oncogenic mechanism?
    Gruel N; El Zein S; Tzanis D; Nicolas N; Maraval A; Fieffe C; Bonvalot S; Caly M; Fuhrmann L; Ait Rais K; Jovelin S; Bonnet C; Pierron G; Watson S
    Genes Chromosomes Cancer; 2023 Jun; 62(6):367-372. PubMed ID: 36744846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic Utility Of Fish For MDM2 In Adipocytic Neoplasms.
    Sarwar S; Mushtaq S; Hassan U; Maqbool H; Qazi R
    J Ayub Med Coll Abbottabad; 2021; 33(4):563-567. PubMed ID: 35124908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
    Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
    Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic Utility and Limitations of Immunohistochemistry of p16, CDK4, and MDM2 and Automated Dual-color In Situ Hybridization of MDM2 for the Diagnosis of Challenging Cases of Dedifferentiated Liposarcoma.
    Kobayashi A; Sakuma T; Fujimoto M; Jimbo N; Hirose T
    Appl Immunohistochem Mol Morphol; 2019; 27(10):758-763. PubMed ID: 31145104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposarcoma in children and young adults: a clinicopathologic and molecular study of 23 cases in one of the largest institutions of China.
    Peng R; Li N; Lan T; Chen H; Du T; He X; Chen M; Xie Y; Zhang Z; Zhao W; Zhang H
    Virchows Arch; 2021 Sep; 479(3):537-549. PubMed ID: 33738541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
    Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
    Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myxiod pleomorphic liposarcoma: a clinicopathological and molecular genetic analysis of six cases].
    Zheng XC; Huang HJ; You J; Lin XY; Chen DR; Zhong D
    Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):738-742. PubMed ID: 35922164
    [No Abstract]   [Full Text] [Related]  

  • 37. Well-differentiated and dedifferentiated liposarcomas.
    Coindre JM; Pédeutour F; Aurias A
    Virchows Arch; 2010 Feb; 456(2):167-79. PubMed ID: 19688222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons learnt from MDM2 fluorescence in-situ hybridisation analysis of 439 mature lipomatous lesions with an emphasis on atypical lipomatous tumour/well-differentiated liposarcoma lacking cytological atypia.
    Vargas AC; Joy C; Cheah AL; Jones M; Bonar F; Brookwell R; Garrone B; Talbot J; Harraway J; Gill AJ; Maclean FM
    Histopathology; 2022 Jan; 80(2):369-380. PubMed ID: 34523152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology.
    Kim YJ; Kim M; Park HK; Yu DB; Jung K; Song K; Choi YL
    Lab Invest; 2019 Sep; 99(9):1309-1320. PubMed ID: 31160689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
    Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
    Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.